# EDGAR Filing Document

**Accession Number:** 0001179929
**File Stem:** 0001179929-23-000034
**Filing Date:** 2023-3
**Character Count:** 6834
**Document Hash:** c7817619805e6f4cd254dcbab50497cc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001179929-23-000034.hdr.sgml**: 20230303

**ACCESSION NUMBER**: 0001179929-23-000034

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230301

**FILED AS OF DATE**: 20230303

**DATE AS OF CHANGE**: 20230303

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Barlow Jeff D.
- **CENTRAL INDEX KEY:** 0001555603

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31719
- **FILM NUMBER:** 23706560

**MAIL ADDRESS:**
- **STREET 1:** 300 UNIVERSITY AVENUE, SUITE 100
- **CITY:** SACRAMENTO
- **STATE:** CA
- **ZIP:** 95825
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MOLINA HEALTHCARE, INC.
- **CENTRAL INDEX KEY:** 0001179929
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOSPITAL & MEDICAL SERVICE PLANS [6324]
- **IRS NUMBER:** 134204626
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 200 OCEANGATE, SUITE 100
- **CITY:** LONG BEACH
- **STATE:** CA
- **ZIP:** 90802
- **BUSINESS PHONE:** 5624353666

**MAIL ADDRESS:**
- **STREET 1:** 200 OCEANGATE, SUITE 100
- **CITY:** LONG BEACH
- **STATE:** CA
- **ZIP:** 90802

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MOLINA HEALTHCARE INC
- **DATE OF NAME CHANGE:** 20020812

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Barlow Jeff D.<br><sub>(Last) (First) (Middle)</sub><br>2180 HARVARD STREET<br>SUITE 400<br><sub>(Street)</sub><br>SACRAMENTO, CA 95815<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Legal Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>MOLINA HEALTHCARE, INC. [ MOH ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-01 |  | F<sup>(1)</sup> |  | 3700 | D | 273.80<sup>(2)</sup> | 62430 | D |  |
| Common Stock | 2023-03-01 |  | A<sup>(3)</sup> |  | 4383 | A | 273.80<sup>(2)</sup> | 66813 | D |  |
| Common Stock | 2023-03-01 |  | A<sup>(4)</sup> |  | 19584 | A | 273.80<sup>(2)</sup> | 86397 | D |  |
| Common Stock | 2023-03-01 |  | F<sup>(5)</sup> |  | 8999 | D | 273.80<sup>(2)</sup> | 77398<sup>(6)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) The shares were applied to the payment of withholding taxes arising in connection with the vesting of 8,048 shares on March 1, 2023.

(2) Represents the closing price of the Issuer's common stock on March 1, 2023.

(3) Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

(4) Shares issued in settlement of performance stock units granted in 2020 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2020, 2021, and 2022.

(5) Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

(6) Shares shall vest as follows:  the 4,383 newly granted shares vest in one-third increments on each of March 1, 2024, March 1, 2025, and March 1, 2026. Additional shares shall vest as follows: 2,676 shares on March 1, 2024 and 1,175 shares on March 1, 2025. The remaining shares are vested.

**Signature:** Jeff D. Barlow  
**Date:** 2023-03-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**